Evidence map›Paper›PMID 40872485›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

From Sea to Therapy: Marine Biomaterials for Drug Delivery and Wound Healing.

Mansi Chilwant, Valentina Paganini, Mariacristina Di Gangi, Sofia Gisella Brignone, Patrizia Chetoni, Susi Burgalassi, Daniela Monti, Silvia Tampucci

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Marine-Derived Polyketides fromACS pharmacology & translational science · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mansi ChilwantDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.
Valentina PaganiniDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-5864-2845
Mariacristina Di GangiDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0003-1317-1119
Sofia Gisella BrignoneDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.
Patrizia ChetoniDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0003-4790-4683
Susi BurgalassiDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-0795-2886
Daniela MontiDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0001-7622-4367
Silvia TampucciDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-8927-6083

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine biomass represents a valuable yet underexploited resource for the development of high-value biomaterials. Recent advances have highlighted the significant potential of marine-derived polysaccharides, proteins, and peptides in biomedical applications, most notably in drug delivery and wound healing. This review provides a comprehensive synthesis of current research on the extraction, processing and pharmaceutical valorization of these biopolymers, with a focus on their structural and functional properties that allow these materials to be engineered into nanocarriers, hydrogels, scaffolds, and smart composites. Key fabrication strategies such as ionic gelation, desolvation, and 3D bioprinting are critically examined for their role in drug encapsulation, release modulation, and scaffold design for regenerative therapies. The review also covers preclinical validation, scale-up challenges, and relevant regulatory frameworks, offering a practical roadmap from sustainable sourcing to clinical application. Special attention is given to emerging technologies, including stimuli-responsive biomaterials and biosensor-integrated wound dressings, as well as to the ethical and environmental implications of marine biopolymer sourcing. By integrating materials science, pharmaceutical technology and regulatory insight, this review aims to provide a multidisciplinary perspective for researchers and industrial stakeholders seeking sustainable and multifunctional pharmaceutical platforms for precision medicine and regenerative therapeutics.

Indexed as

alginatebioeconomybiomassblue biotechnologychitosancollagenindustrial by-productsmarine biomaterialspeptidespolysaccharidesproteinssustainable drug deliverywound healing

Identifiers

PMID40872485
PMCPMC12388878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.